-
1
-
-
0027322448
-
Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
-
Z.G. Brown, X.Q. Zhao, D.E. Sacco, J.J. Albers Lipid lowering and plaque regression New insights into prevention of plaque disruption and clinical events in coronary disease Circulation 87 1993 1781 1791
-
(1993)
Circulation
, vol.87
, pp. 1781-1791
-
-
Brown, Z.G.1
Zhao, X.Q.2
Sacco, D.E.3
Albers, J.J.4
-
2
-
-
0003132710
-
Current concepts in cardiovascular pathology: The role of LDL cholesterol in plaque rupture and stabilization
-
P. Libby, U. Schoenbeck, F. Mach, A.P. Selwyn, P. Ganz Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization Am J Med 104 suppl 1998 14S 18S
-
(1998)
Am J Med
, vol.104
, Issue.SUPPL.
-
-
Libby, P.1
Schoenbeck, U.2
MacH, F.3
Selwyn, A.P.4
Ganz, P.5
-
3
-
-
0035799341
-
Inflammation and thrombosis: The clot thickens
-
P. Libby, D.I. Simon Inflammation and thrombosis: the clot thickens Circulation 103 2001 1718 1720
-
(2001)
Circulation
, vol.103
, pp. 1718-1720
-
-
Libby, P.1
Simon, D.I.2
-
4
-
-
0037162340
-
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: Effects of statin therapy
-
F. Cipollone, A. Mezzetti, E. Porreca, C. Di Febbo, M. Nutini, M. Fazia, A. Falco, F. Cuccurullo, G. Davi Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy Circulation 106 2002 399 402
-
(2002)
Circulation
, vol.106
, pp. 399-402
-
-
Cipollone, F.1
Mezzetti, A.2
Porreca, E.3
Di Febbo, C.4
Nutini, M.5
Fazia, M.6
Falco, A.7
Cuccurullo, F.8
Davi, G.9
-
5
-
-
0015352648
-
Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets
-
M.L. Armstrong, M.B. Megan Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets Circ Res 30 1972 675 680
-
(1972)
Circ Res
, vol.30
, pp. 675-680
-
-
Armstrong, M.L.1
Megan, M.B.2
-
6
-
-
0032584177
-
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
-
U. Laufs, V. La Fata, J. Plutzky Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
-
(1998)
Circulation
, vol.97
, pp. 1129-1135
-
-
Laufs, U.1
La Fata, V.2
Plutzky, J.3
-
8
-
-
0027381860
-
Endothelium-dependent effects of converting-enzyme inhibitors
-
P.M. Vanhoutte, C.M. Boulanger, S.C. Illiano, T. Nagao, M. Vidal, J.V. Mombouli Endothelium-dependent effects of converting-enzyme inhibitors J Cardiovasc Pharmacol 22 suppl 1993 S10 S16
-
(1993)
J Cardiovasc Pharmacol
, vol.22
, Issue.SUPPL.
-
-
Vanhoutte, P.M.1
Boulanger, C.M.2
Illiano, S.C.3
Nagao, T.4
Vidal, M.5
Mombouli, J.V.6
-
9
-
-
0025343047
-
Effects of captopril on atherosclerosis in cynomolgus monkeys
-
G. Aberg, P. Ferrer Effects of captopril on atherosclerosis in cynomolgus monkeys J Cardiovasc Pharmacol 15 suppl 1990 S65 S72
-
(1990)
J Cardiovasc Pharmacol
, vol.15
, Issue.SUPPL.
-
-
Aberg, G.1
Ferrer, P.2
-
10
-
-
0028125199
-
Antiatherogenic effects of beta-adrenergic blocking agents: Theoretical, experimental, and epidemiologic considerations
-
J.R. Kaplan, S.B. Manuck Antiatherogenic effects of beta-adrenergic blocking agents: theoretical, experimental, and epidemiologic considerations Am Heart J 128 1994 1316 1328
-
(1994)
Am Heart J
, vol.128
, pp. 1316-1328
-
-
Kaplan, J.R.1
Manuck, S.B.2
-
11
-
-
0036158710
-
Effect of controlled release/extend release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: A 3-year randomized study
-
O. Wiklund, J. Hulthe, J. Wikstrand, C. Schmidt, S.O. Olofsson, G. Bondjers Effect of controlled release/extend release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study Stroke 33 2002 572 577
-
(2002)
Stroke
, vol.33
, pp. 572-577
-
-
Wiklund, O.1
Hulthe, J.2
Wikstrand, J.3
Schmidt, C.4
Olofsson, S.O.5
Bondjers, G.6
-
12
-
-
0037015289
-
Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice
-
T. Cyrus, S. Sung, L. Zhao, C.D. Funk, S. Tang, D. Pratico Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice Circulation 106 2002 1282 1287
-
(2002)
Circulation
, vol.106
, pp. 1282-1287
-
-
Cyrus, T.1
Sung, S.2
Zhao, L.3
Funk, C.D.4
Tang, S.5
Pratico, D.6
-
13
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
-
(1997)
N Engl J Med
, vol.336
, pp. 973-979
-
-
Ridker, P.M.1
Cushman, M.2
Stampfer, M.J.3
Tracy, R.P.4
Hennekens, C.H.5
-
14
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial Investigators
-
F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M. Arnold, C.C. Wun, B.R. Davis, E. Braunwald The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events Trial Investigators N Engl J Med 335 1996 1001 1009
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
Brown, L.7
Warnica, J.W.8
Arnold, J.M.9
Wun, C.C.10
Davis, B.R.11
Braunwald, E.12
-
15
-
-
0028267313
-
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: The Canadian Coronary Atherosclerosis Intervention Trial
-
D. Waters, L. Higginson, P. Gladstone, B. Kimball, M. Le May, S.J. Boccuzzi, J. Lesperance Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography The Canadian Coronary Atherosclerosis Intervention Trial Circulation 89 1994 959 968
-
(1994)
Circulation
, vol.89
, pp. 959-968
-
-
Waters, D.1
Higginson, L.2
Gladstone, P.3
Kimball, B.4
Le May, M.5
Boccuzzi, S.J.6
Lesperance, J.7
-
16
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
-
J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, P.W. MacFarlane, J.H. McKillop, C.J. Packard Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
MacFarlane, P.W.6
McKillop, J.H.7
Packard, C.J.8
-
17
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
18
-
-
0026786643
-
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after MI: Results of the survival and ventricular enlargement trial
-
M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after MI Results of the survival and ventricular enlargement trial N Engl J Med 327 1992 669 677
-
(1992)
N Engl J Med
, vol.327
, pp. 669-677
-
-
Pfeffer, M.A.1
Braunwald, E.2
Moye, L.A.3
Basta, L.4
Brown Jr., E.J.5
Cuddy, T.E.6
Davis, B.R.7
Geltman, E.M.8
Goldman, S.9
Flaker, G.C.10
-
19
-
-
0010838455
-
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients: ACE-Inhibitor MI Collaborative Group
-
M.D. Flather, S. Yusuf, L. Kober, M. Pfeffer, A. Hall, G. Murray, C. Torp-Pedersen, S. Ball, J. Pogue, L. Moye, E. Braunwald Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients ACE-Inhibitor MI Collaborative Group Lancet 355 2000 1575 1581
-
(2000)
Lancet
, vol.355
, pp. 1575-1581
-
-
Flather, M.D.1
Yusuf, S.2
Kober, L.3
Pfeffer, M.4
Hall, A.5
Murray, G.6
Torp-Pedersen, C.7
Ball, S.8
Pogue, J.9
Moye, L.10
Braunwald, E.11
-
20
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
-
S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
21
-
-
0027371696
-
Effects of beta-blockers and calcium channel blockers in acute myocardial infarction
-
P.H. Held, S. Yusuf Effects of beta-blockers and calcium channel blockers in acute myocardial infarction Eur Heart J 14 1993 18 25
-
(1993)
Eur Heart J
, vol.14
, pp. 18-25
-
-
Held, P.H.1
Yusuf, S.2
-
22
-
-
0024406369
-
Final report on the aspirin component of the ongoing Physicians' Health Study
-
Steering Committee of the Physicians' Health Study Research Group
-
Steering Committee of the Physicians' Health Study Research Group Final report on the aspirin component of the ongoing Physicians' Health Study N Engl J Med 321 1989 129 135
-
(1989)
N Engl J Med
, vol.321
, pp. 129-135
-
-
-
23
-
-
0026485080
-
Double-blind trial of aspirin in primary prevention of MI in patients with stable chronic angina pectoris: The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group
-
S. Juul-Moller, N. Edvardsson, B. Jahnmatz, A. Rosen, S. Sorensen, R. Omblus Double-blind trial of aspirin in primary prevention of MI in patients with stable chronic angina pectoris The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group Lancet 340 1992 1421 1425
-
(1992)
Lancet
, vol.340
, pp. 1421-1425
-
-
Juul-Moller, S.1
Edvardsson, N.2
Jahnmatz, B.3
Rosen, A.4
Sorensen, S.5
Omblus, R.6
-
24
-
-
0034702531
-
Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis
-
J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, Y. Wong, M. Bernardes-Silva, M. Ward Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis BMJ 321 2000 208 213
-
(2000)
BMJ
, vol.321
, pp. 208-213
-
-
Danesh, J.1
Whincup, P.2
Walker, M.3
Lennon, L.4
Thomson, A.5
Appleby, P.6
Wong, Y.7
Bernardes-Silva, M.8
Ward, M.9
-
25
-
-
0037024326
-
Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: A randomized, double-blind, placebo-controlled trial
-
P. Wiesli, W. Czerwenka, A. Meniconi, F.E. Maly, U. Hoffmann, W. Vetter, G. Schulthess Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial Circulation 105 2002 2646 2652
-
(2002)
Circulation
, vol.105
, pp. 2646-2652
-
-
Wiesli, P.1
Czerwenka, W.2
Meniconi, A.3
Maly, F.E.4
Hoffmann, U.5
Vetter, W.6
Schulthess, G.7
-
26
-
-
0037015254
-
Stone A, Mendall MA, Northfield J, Edger TM, Risley P, Poloniecki J, Camm AJ, Northfield TC
-
Stone A, Mendall MA, Northfield J, Edger TM, Risley P, Poloniecki J, Camm AJ, Northfield TC Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames trial of antibiotics in myocardial infarction and Unstable Angina (STAMINA) Circulation 106 2002 1219 1223
-
(2002)
Effect of Treatment for Chlamydia Pneumoniae and Helicobacter Pylori on Markers of Inflammation and Cardiac Events in Patients with Acute Coronary Syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA) Circulation
, vol.106
, pp. 1219-1223
-
-
-
27
-
-
0033514107
-
Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association
-
AHA Science Advisory D.C.
-
D.C. Tribble AHA Science Advisory Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and beta-carotene: a statement for healthcare professionals from the American Heart Association Circulation 99 1999 591 595
-
(1999)
Circulation
, vol.99
, pp. 591-595
-
-
Tribble1
-
28
-
-
0036140785
-
Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering
-
S.N. Doshi, I.F. McDowell, S.J. Moat, N. Payne, H.J. Durrant, M.J. Lewis, J. Goodfellow Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering Circulation 105 2002 22 26
-
(2002)
Circulation
, vol.105
, pp. 22-26
-
-
Doshi, S.N.1
McDowell, I.F.2
Moat, S.J.3
Payne, N.4
Durrant, H.J.5
Lewis, M.J.6
Goodfellow, J.7
-
29
-
-
0036623832
-
Clinical trials update: Highlights of the scientific sessions of the American College of Cardiology 2002
-
Coletta A, Thackray S, Nikitin N, Cleland JG. Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002. Eur J Heart Fail 2002:381-388.
-
(2002)
Eur J Heart Fail
, pp. 381-388
-
-
Coletta, A.1
Thackray, S.2
Nikitin, N.3
Cleland, J.G.4
-
30
-
-
0035203840
-
Antioxidants and atherosclerotic cardiovascular disease: Unresolved issues
-
D.C. Tribble Antioxidants and atherosclerotic cardiovascular disease: unresolved issues Coron Artery Dis 7 2001 541 546
-
(2001)
Coron Artery Dis
, vol.7
, pp. 541-546
-
-
Tribble, D.C.1
-
31
-
-
0038648465
-
Secondary prevention with folic acid: Effects on clinical outcomes
-
A. Liem, G.H. Reynierse-Buitenwerf, A.H. Zwinderman, J.W. Jukema, D.J. van Veldhuisen Secondary prevention with folic acid: effects on clinical outcomes J Am Coll Cardiol 41 2003 2105 2113
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 2105-2113
-
-
Liem, A.1
Reynierse-Buitenwerf, G.H.2
Zwinderman, A.H.3
Jukema, J.W.4
Van Veldhuisen, D.J.5
-
32
-
-
0037160969
-
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
LIFE Study Group K.
-
L.H. Lindholm, H. Ibsen, B. Dahlof, R.B. Devereux, G. Beevers, U. de Faire, F. Fyhrquist, S. Julius, S.E. Kjeldsen, K. Kristiansson LIFE Study Group Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 1004 1010
-
(2002)
Lancet
, vol.359
, pp. 1004-1010
-
-
Lindholm, L.H.1
Ibsen, H.2
Dahlof, B.3
Devereux, R.B.4
Beevers, G.5
De Faire, U.6
Fyhrquist, F.7
Julius, S.8
Kjeldsen, S.E.9
Kristiansson10
-
33
-
-
0037137299
-
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
-
P.M. Kris-Etherton, W.S. Harris, L.J. Appel Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 2002 2747 2757
-
(2002)
Circulation
, vol.106
, pp. 2747-2757
-
-
Kris-Etherton, P.M.1
Harris, W.S.2
Appel, L.J.3
-
34
-
-
0028855987
-
Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest
-
D.S. Siscovick, T.E. Raghunathan, I. King, S. Weinmann, K.G. Wicklund, J. Albright, V. Bovbjerg, P. Arbogast, H. Smith, L.H. Kushi Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest JAMA 274 1995 1363 1367
-
(1995)
JAMA
, vol.274
, pp. 1363-1367
-
-
Siscovick, D.S.1
Raghunathan, T.E.2
King, I.3
Weinmann, S.4
Wicklund, K.G.5
Albright, J.6
Bovbjerg, V.7
Arbogast, P.8
Smith, H.9
Kushi, L.H.10
-
35
-
-
0035698468
-
The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: Heart and brain
-
A. Leaf The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: heart and brain Lipids 36 2001 S107 S110
-
(2001)
Lipids
, vol.36
-
-
Leaf, A.1
-
36
-
-
0036124659
-
N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials
-
H.C. Bucher, P. Hengstler, C. Schindler, G. Meier N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials Am J Med 112 2002 298 304
-
(2002)
Am J Med
, vol.112
, pp. 298-304
-
-
Bucher, H.C.1
Hengstler, P.2
Schindler, C.3
Meier, G.4
-
37
-
-
0025347391
-
Blood pressure, stroke, and coronary heart disease: Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
-
R. Collins, R. Peto, S. MacMahon, P. Hebert, N.H. Fiebach, K.A. Eberlein, J. Godwin, N. Qizilbash, J.O. Taylor, C.H. Hennekens Blood pressure, stroke, and coronary heart disease Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 335 1990 827 838
-
(1990)
Lancet
, vol.335
, pp. 827-838
-
-
Collins, R.1
Peto, R.2
MacMahon, S.3
Hebert, P.4
Fiebach, N.H.5
Eberlein, K.A.6
Godwin, J.7
Qizilbash, N.8
Taylor, J.O.9
Hennekens, C.H.10
-
38
-
-
0002266162
-
Antihypertensive drug therapy: Effects on stroke and coronary heart disease
-
J.D. Swales Blackwell Scientific Publications Oxford
-
R. Collins, R. Peto Antihypertensive drug therapy: effects on stroke and coronary heart disease J.D. Swales Textbook of Hypertension 1994 Blackwell Scientific Publications Oxford 1156 1164
-
(1994)
Textbook of Hypertension
, pp. 1156-1164
-
-
Collins, R.1
Peto, R.2
-
39
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
The ALLHAT Research Group
-
The ALLHAT Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
-
40
-
-
0037047092
-
Cyclooxygenase-2 inhibition and cardiovascular events
-
B. Pitt, C. Pepine, J.T. Willerson Cyclooxygenase-2 inhibition and cardiovascular events Circulation 106 2002 167 169
-
(2002)
Circulation
, vol.106
, pp. 167-169
-
-
Pitt, B.1
Pepine, C.2
Willerson, J.T.3
-
41
-
-
0031744030
-
Role of inflammation and metalloproteinases in plaque disruption and thrombosis
-
P.K. Shah Role of inflammation and metalloproteinases in plaque disruption and thrombosis Vasc Med 3 1998 199 206
-
(1998)
Vasc Med
, vol.3
, pp. 199-206
-
-
Shah, P.K.1
-
42
-
-
0037432146
-
Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice
-
P. Naghavi, S. Wyde, M. Litovsky Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice Circulation 107 2003 762 768
-
(2003)
Circulation
, vol.107
, pp. 762-768
-
-
Naghavi, P.1
Wyde, S.2
Litovsky, M.3
-
43
-
-
0037035475
-
Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: The FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study
-
E.P. Gurfinkel, L. de la Fuente, O. Mendiz, B. Mautner Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study Circulation 105 2002 2143 2147
-
(2002)
Circulation
, vol.105
, pp. 2143-2147
-
-
Gurfinkel, E.P.1
De La Fuente, L.2
Mendiz, O.3
Mautner, B.4
-
44
-
-
0030590746
-
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
-
CAPRIE Steering Committee
-
CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
-
(1996)
Lancet
, vol.348
, pp. 1329-1339
-
-
-
45
-
-
0035899289
-
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
-
The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators
-
The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
-
(2001)
N Engl J Med
, vol.345
, pp. 494-502
-
-
-
46
-
-
17744404395
-
Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients
-
L. Cominacini, U. Garbin, A. Pasini, M. Campagnola, A. Davoli, E. Foot, G. Sighieri, A.M. Sironi, V. Lo Cascio, E. Ferrannini Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients Diabetes 47 1998 130 133
-
(1998)
Diabetes
, vol.47
, pp. 130-133
-
-
Cominacini, L.1
Garbin, U.2
Pasini, A.3
Campagnola, M.4
Davoli, A.5
Foot, E.6
Sighieri, G.7
Sironi, A.M.8
Lo Cascio, V.9
Ferrannini, E.10
-
47
-
-
0033864582
-
Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
-
A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J Clin Invest 106 2000 523 531
-
(2000)
J Clin Invest
, vol.106
, pp. 523-531
-
-
Li, A.C.1
Brown, K.K.2
Silvestre, M.J.3
Willson, T.M.4
Palinski, W.5
Glass, C.K.6
-
48
-
-
1842815777
-
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol
-
M.E. Brousseau, E.J. Schaefer, M.L. Wolfe, L.T. Bloedon, A.G. Digenio, R.W. Clark, J.P. Mancuso, D.J. Rader Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol N Engl J Med 350 2004 1505 1515
-
(2004)
N Engl J Med
, vol.350
, pp. 1505-1515
-
-
Brousseau, M.E.1
Schaefer, E.J.2
Wolfe, M.L.3
Bloedon, L.T.4
Digenio, A.G.5
Clark, R.W.6
Mancuso, J.P.7
Rader, D.J.8
|